New-onset Polymyalgia Rheumatica Following the Administration of the Pfizer-BioNTech COVID-19 Vaccine

We herein report the case of an 80-year-old Japanese woman who presented to our hospital with bilateral pain in the shoulders and hips lasting for a month since 2 days after the second dose of the BNT162b2 COVID-19 vaccine. Her physical findings, laboratory data, and ultrasonographic findings of bil...

Full description

Saved in:
Bibliographic Details
Published in:Internal Medicine 2022/03/01, Vol.61(5), pp.749-753
Main Authors: Osada, Atsumu, Sakuragi, Chinatsu, Toya, Chisashi, Mitsuo, Akiko
Format: Article
Language:English
Subjects:
adverse effect
Aged, 80 and over
BNT162 Vaccine
Case Report
Coronaviruses
COVID-19
COVID-19 vaccine
COVID-19 vaccines
COVID-19 Vaccines - adverse effects
Differential diagnosis
Female
Humans
Internal medicine
Myalgia
Polymyalgia rheumatica
Polymyalgia Rheumatica - diagnosis
Polymyalgia Rheumatica - drug therapy
Prednisolone
SARS-CoV-2
Tenosynovitis
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We herein report the case of an 80-year-old Japanese woman who presented to our hospital with bilateral pain in the shoulders and hips lasting for a month since 2 days after the second dose of the BNT162b2 COVID-19 vaccine. Her physical findings, laboratory data, and ultrasonographic findings of bilateral biceps tenosynovitis and lateral subacromial bursitis were consistent with a diagnosis of polymyalgia rheumatica (PMR). She was successfully treated with oral prednisolone 15 mg/day. Although a causal relationship could not be definitively confirmed, PMR should be considered as a differential diagnosis in cases of persistent myalgia after administration of the BNT162b2 vaccine.
ISSN:0918-2918
1349-7235
DOI:10.2169/internalmedicine.8651-21